High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study

Drug Discoveries & Therapeutics
Fabiana MalloneAntonietta Moramarco

Abstract

The aim of this study is to investigate the potential neuroprotective effect of high-doses vitamins B1, B6 and B12 in patients with relapsing-remitting multiple sclerosis (RRMS) and persistent visual loss after acute optic neuritis (AON). Sixteen patients (20 eyes) diagnosed with RRMS and visual permanent disability following AON were enrolled for the present open, pilot study. Each patient was treated with oral high-doses 300 mg of vitamin B1, 450 mg of vitamin B6 and 1,500 mcg of vitamin B12, as add-on treatment to concomitant disease-modifying therapies (DMTs) for consecutive 90 days. Outcome measures were to determine changes from baseline to month three in visual acuity (VA) and visual field (VF) testing, with correlations with clinical parameters. Logistical regression was performed to evaluate predictors of final VA. A statistically significant improvement was registered in visual acuity (p = 0.002) and foveal sensitivity threshold (FT) (p = 0.006) at follow-up compared to baseline. A similar trend was demonstrated for mean deviation (MD) (p < 0.0001), and pattern standard deviation (PSD) (p < 0.0001). Age at the time of inclusion was positively correlated with latency time (rho = 0.47, p = 0.03), while showing a negativ...Continue Reading

References

May 1, 1990·Acta Neurologica Scandinavica·R F CrellinE H Reynolds
May 1, 1994·General Hospital Psychiatry·D M GruenerH L Field
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabrizio G MastronardiMario A Moscarello
Sep 15, 2004·Archives of Neurology·Istvan PirkoBrian G Weinshenker
May 18, 2005·Journal of the Neurological Sciences·Ariel MillerYanina Galboiz
Jun 6, 2007·Multiple Sclerosis : Clinical and Laboratory Research·F G MastronardiM A Moscarello
Dec 18, 2007·Journal of Neurology·C RussoUmberto Aguglia
Nov 15, 2008·Lancet Neurology·Alan J Thompson
Jun 29, 2011·Protein Science : a Publication of the Protein Society·Florence BourquinMarkus Gerhard Grütter
Feb 7, 2012·BMC Clinical Pharmacology·Howard A SmithlineDavid J Greenblatt
Aug 14, 2012·The Open Ophthalmology Journal·Hedieh Hoorbakht, Farid Bagherkashi
Jan 31, 2013·European Journal of Histochemistry : EJH·G ScarsellaN Pescosolido
Mar 7, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Laurence JasseCaroline Tilikete
Jul 19, 2013·BMJ Case Reports·Antonio CostantiniAntonietta Zappone
Jul 27, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhe JiZun-Ji Ke
Dec 11, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nicola PescosolidoMarcella Nebbioso
Mar 20, 2015·Multiple Sclerosis and Related Disorders·Frédéric SedelAyman Tourbah
Feb 13, 2016·Multiple Sclerosis : Clinical and Laboratory Research·A ScalfariP A Muraro
Aug 19, 2016·Drug Discoveries & Therapeutics·Dalal K BubshaitRaashda A Sulaiman
Mar 2, 2017·Journal of Geriatric Psychiatry and Neurology·Dong-Mei ZhangXiao-Ping Cui
Nov 17, 2017·Multiple Sclerosis and Related Disorders·Gary Birnbaum, Jessica Stulc
Dec 26, 2017·Lancet Neurology·Alan J ThompsonJeffrey A Cohen
Aug 10, 2018·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Francisco CoretBonaventura Casanova
Oct 5, 2018·Journal of Neurology·Laurie McLaughlinSimon A Broadley
Oct 10, 2018·Current Opinion in Neurology·Jiwon OhXavier Montalban
Sep 7, 2019·CNS Neuroscience & Therapeutics·Carlos Alberto Calderón-Ospina, Mauricio Orlando Nava-Mesa
Jun 17, 2020·Multiple Sclerosis and Related Disorders·Kevin YanEric Druyts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.